BridgeBio Pharma, Inc.
$73.28
$1.61(2.25%)
BridgeBio Pharma, Inc.
BBIO
$73.28
$1.61(2.25%)
BridgeBio Pharma, Inc.
BBIO
NASDAQ
$73.28
$1.61(2.25%)
Chart
Key stats
52-Week Range$73.28
$31.77
$84.94
Market capitalization
$13.33BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
-18.54Basic EPS (TTM)
$-3.79Net income (TTM)
$-729.31MRevenue (TTM)
$502.08MAvg. volume
2.61MBeta (1Y)
1.09Employees
725Market capitalization
$13.33BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
-18.54Basic EPS (TTM)
$-3.79Net income (TTM)
$-729.31MRevenue (TTM)
$502.08MAvg. volume
2.61MBeta (1Y)
1.09Employees
725Screener Quick Check
Sign in to check this stock against your screeners
Sign InAbout BridgeBio Pharma, Inc.
Sector
Healthcare
Industry
Biotechnology
CEO
Neil Kumar
Website
www.bridgebio.comHeadquarters
421 Kipling Street, Palo Alto, CA, 94301
IPO Date
2019-06-27
Identifiers
ISIN
US10806X1028Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases....
Related Stocks
$147.21
1D:
-0.5%
1Y:
269.9%
US76155X1000Healthcare
Mkt Cap
$31.30B
P/E Ratio TTM
-23.4
Revenue TTM
$0.00
Beta
1.01
Earnings TTM
$-1.13B
Dividend Yield TTM
0.00%
$28.32
1D:
-0.1%
1Y:
144.8%
BMG762791017Healthcare
Mkt Cap
$20.27B
P/E Ratio TTM
-24.0
Revenue TTM
$13.31M
Beta
1.21
Earnings TTM
$-809.24M
Dividend Yield TTM
0.00%
Dividend Overview
This company does not pay dividends
Financials
Performance
Margin trends
Debt level and coverage
Earnings
Actual
Estimate
Performance
Margin trends
Debt level and coverage
Earnings
Actual
Estimate